In vivo anti-tumour activity of corilagin on Hep3B hepatocellular carcinoma.
Hau
Desmond Kwok-Po
DK
Research and Development Division, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
Zhu
Guo-Yuan
GY
Leung
Alexander Kai-Man
AK
Wong
Raymond Siu-Ming
RS
Cheng
Gregory Yin-Ming
GY
Lai
Paul Bo-San
PB
Tong
Sze-Wai
SW
Lau
Fung-Yi
FY
Chan
Kit-Wah
KW
Wong
Wai-Yeung
WY
Lam
Kim-Hung
KH
Cheng
Chor-Hing
CH
Cheung
Filly
F
Chui
Chung-Hin
CH
Gambari
Roberto
R
Fong
David Wang-Fun
DW
D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D045744:Cell Line, Tumor; D005960:Glucosides / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D047348:Hydrolyzable Tannins; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008113:Liver Neoplasms / Q000188:drug therapy*; D051379:Mice; D008819:Mice, Nude; D008517:Phytotherapy; D010936:Plant Extracts / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D023041:Xenograft Model Antitumor Assays
D000972:Antineoplastic Agents, Phytogenic; D005960:Glucosides; D047348:Hydrolyzable Tannins; D010936:Plant Extracts; C049096:corilagin